These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26149783)

  • 41. Safe administration of iron dextran to a patient who reacted to the test dose.
    Monaghan MS; Glasco G; St John G; Bradsher RW; Olsen KM
    South Med J; 1994 Oct; 87(10):1010-2. PubMed ID: 7939912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron requirements in hemodialysis.
    Sargent JA; Acchiardo SR
    Blood Purif; 2004; 22(1):112-23. PubMed ID: 14732819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of iron deficiency anemia: are monomeric iron compounds suitable for parenteral administration?
    Gupta A; Crumbliss AL
    J Lab Clin Med; 2000 Nov; 136(5):371-8. PubMed ID: 11079464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
    Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
    Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
    Malinovskaja K; Laaksonen T; Hirvonen J
    Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease).
    Mehmood T; Auerbach M; Earley CJ; Allen RP
    Sleep Med; 2014 Dec; 15(12):1473-6. PubMed ID: 25441748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia.
    Sharma VR; Brannon MA; Carloss EA
    South Med J; 2004 Sep; 97(9):887-9. PubMed ID: 15455980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of iron deficiency.
    Callender ST
    Clin Haematol; 1982 Jun; 11(2):327-38. PubMed ID: 7042154
    [No Abstract]   [Full Text] [Related]  

  • 50. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
    Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
    Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal drug delivery devices for chronotherapy.
    Hradetzky D
    Med Device Technol; 2008; 19(3):45-7. PubMed ID: 18557410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy.
    Komolafe JO; Kuti O; Ijadunola KT; Ogunniyi SO
    J Obstet Gynaecol; 2003 Nov; 23(6):628-31. PubMed ID: 14617464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Iron deficiency anemia in adults. Main symptoms: fatigue, pallor, (stress-) dyspnea, headache, concentration disorders].
    Krayenbuehl PA; Naumann KU; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Aug; 96(34):1241-7; quiz 1248. PubMed ID: 17853781
    [No Abstract]   [Full Text] [Related]  

  • 54. Microcytic anemia with iron malabsorption: an inherited disorder of iron metabolism.
    Hartman KR; Barker JA
    Am J Hematol; 1996 Apr; 51(4):269-75. PubMed ID: 8602626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
    Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
    Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of intramuscular and oral use of antianemic iron preparations in suckling pigs].
    Dilov P
    Vet Med Nauki; 1975; 12(1):76-81. PubMed ID: 1209997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical management. Where medicine meets management. Pumping iron.
    Peebles G
    Health Serv J; 2004 May; 114(5907):28-9. PubMed ID: 15188729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing the use of parenteral iron in end-stage renal disease patients: focus on issues of infection and cardiovascular disease. Introduction.
    Owen WF
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S1-2. PubMed ID: 10516368
    [No Abstract]   [Full Text] [Related]  

  • 60. Goodbye oral iron therapy?
    Forman E
    Pediatr Blood Cancer; 2013 Nov; 60(11):1731. PubMed ID: 23900795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.